
Heralding Hope: Understanding Huntington Disease Through Genetic Testing
Explore Huntington disease through genetic testing, covering diagnosis, predictive and carrier testing, and insights from the Malian study to enhance understanding.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore Huntington disease through genetic testing, covering diagnosis, predictive and carrier testing, and insights from the Malian study to enhance understanding.

Explore the impact of genetic testing on diagnosing and managing Hyper-IgE Recurrent Infection Syndrome 1, enhancing personalized treatment and family planning.

Explore the impact of genetic testing on diagnosing and managing hypercholesterolemia type B, focusing on early diagnosis, tailored treatments, and family risk assessment.

Unlock personalized care with genetic testing for Familial Hypercholesterolemia. Early diagnosis, tailored treatments, and family risk assessment improve outcomes.

Gain insights into hyperglycinuria, a rare metabolic disorder, through genetic testing. Discover how it improves diagnosis, treatment, and patient care outcomes.

Explore how genetic testing unveils the role of the LPL gene, particularly the D151N variant, in familial combined hyperlipidemia and early coronary disease.

Unlock the potential of genetic testing for Hyperostosis Cranialis Interna. Early diagnosis, personalized treatments, and family planning improve outcomes.

Explore how genetic testing transforms Hyperparathyroidism 1 care by identifying mutations, personalizing treatments, and guiding family counseling for better outcomes.